Register
Login:
Share:
Email Facebook Twitter

Market analyst Rajan Dhall talks about the financial market Watch here

Market analyst Rajan Dhall talks about the financial market


Valirx Share Chat (VAL)



Share Price: 2.10Bid: 2.00Ask: 2.20Change: 0.00 (0.00%)No Movement on Valirx
Spread: 0.20Spread as %: 10.00%Open: 2.025High: 2.10Low: 2.025Yesterday’s Close: 2.10


Share Discussion for Valirx


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Noise
Posts: 2,054
Off Topic
Opinion:No Opinion
Price:2.10
RE: Interesting article !
Today 00:26
To get on bbc you have to know the right person and the secret handshake.
 
tillidjohan
Posts: 34
Off Topic
Opinion:No Opinion
Price:2.10
View Thread (2)
RE: Interesting article !
Sat 16:22
Great article yet how can CEO of Valirx tell shareholders a similar Valirx treatment 'Bloody Works' yet never gets a mention in the press?
HardToHandle
Posts: 1,211
Off Topic
Opinion:No Opinion
Price:2.10
Interesting article !
Sat 08:28
Will NHS approve new cancer drug which avoids pain of chemotherapy? 

http://dailym.ai/2t1dP7D
PI101
Posts: 922
Off Topic
Opinion:No Opinion
Price:2.10
View Thread (2)
RE: Rns
Sat 05:43
I'm not so sure. Im inclined to agree with him.

This board are a colossal bunch of c***s that couldn't organise a p***up in a brewery. They're utterly shameless to boot, I'm honesty astounded to the core that share holders have put up with their behaviour for as long as they have.

90.6% down here now.

That's some excellent work generating shareholder value there Valirx. Excellent work indeed. Give yourselves a bonus!
spre
Posts: 32
Off Topic
Opinion:No Opinion
Price:2.10
Multiskint
Fri 20:51
How's it going , when I called GM a sweating looking tramp a few years ago. After one of his presentations .. and he should look a bit better on are money .... share price was around 40p... you told me he he will prove me wrong....and you will love it when he shuts scum like me up....who's the scum... board or investors....? Multiqunt.
johngilchrist
Posts: 8,555
Off Topic
Opinion:No Opinion
Price:2.025
Advisory Board RNS
Fri 11:53
I understand that the rationale of forming the advisory board, is partly to related to cost reduction.

Part time NED's charge for their services through more expensive ad-hoc consultancy fees. So the new arrangement should save money.

That aspect wasn't communicated particularly well in the RNS.
leapfrog
Posts: 2,713
Observation
Opinion:No Opinion
Price:2.025
.? . ?
Thu 23:40
Why on earth would the BOD want to buy a third of the company? They would then have to take out the rest of us at 2pps or there abouts wake up.
Multibagger1
Posts: 4,923
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:2.025
View Thread (2)
Draey
Thu 19:28
Your post this morning is disgraceful.

Let's hope 201 or 401 work and benefit patients in great need of treatment. How would you refer to the BOD then?

Get a grip!
CHELSEA7
Posts: 27,274
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:2.025
RE: What is
Thu 15:16
Hi Teamhanz, for the few occasions I need to I just do dummy sells/buys on the H/L platform. Certainly up to date GL
Noise
Posts: 2,054
Off Topic
Opinion:No Opinion
Price:2.025
View Thread (2)
RE: RE: New Advisory Board
Thu 15:10
Optimist thought: board of advisors would suggest there is something moderate to be advised on, or would possibly allow reduced costs

Pessimistic thought: it would conveniently allow Satu to accept a low/moderate offer and be able to pass the buck by saying 'an independent board of advisors approved the deal'.

It's a massive 6 months for valirx. The pathway to potentially hundreds of millions, or total failure. I for one like the potential risk/reward on offer. But accept historical statistics are against us.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.